ASX:OSL

ONCOSIL MEDICAL LTD

Bell Potter

After a quiet year for global takeover activity in the pharmaceutical sector in 2017, Trump's tax cuts have fired up the appetite for acquisitions in the sector. US firms in particular have been active in snapping up undervalued Australian biotech assets. Show More

Mathan Somasundaram

Local market fell after starting positive and then made a slight recovery to deliver third consecutive negative day. Commodities were smacked overnight and that meant resource sector was always going to be under pressure. Banks started positive on NAB result but then faded into negative territory as market worried about... Show More

A busy AGM month this month and I can't hope to touch on all the AGMs...but I have a note on All the Majors AGMs happening this month https://subscriber.theexecutiveremunerationreporter.com.au/archives/15106, the two strike AGMs happening this month https://subscriber.theexecutiveremunerationreporter.com.au/archives/15104 and a note with a selection of AGMs and General Meetings occurring in... Show More

Too early for the mini AGM season, the focus this month is on general meetings and a key theme is share placements. I take a look at the GMs scheduled for Tassal Group (financial assistance), Ausenco, Coppermoly, Impedimed, nearmap, Oncosil Medical, Programmed Maintenance Services. This month's note takes a look... Show More